BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17698570)

  • 1. Antibody-independent, CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins.
    Basset A; Thompson CM; Hollingshead SK; Briles DE; Ades EW; Lipsitch M; Malley R
    Infect Immun; 2007 Nov; 75(11):5460-4. PubMed ID: 17698570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization.
    Malley R; Trzcinski K; Srivastava A; Thompson CM; Anderson PW; Lipsitch M
    Proc Natl Acad Sci U S A; 2005 Mar; 102(13):4848-53. PubMed ID: 15781870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection Elicited by Nasal Immunization with Recombinant Pneumococcal Surface Protein A (rPspA) Adjuvanted with Whole-Cell Pertussis Vaccine (wP) against Co-Colonization of Mice with Streptococcus pneumoniae.
    Tostes RO; Rodrigues TC; da Silva JB; Schanoski AS; Oliveira ML; Miyaji EN
    PLoS One; 2017; 12(1):e0170157. PubMed ID: 28103277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal Immunization with the Commensal
    Shekhar S; Khan R; Schenck K; Petersen FC
    Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30683742
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide.
    Malley R; Srivastava A; Lipsitch M; Thompson CM; Watkins C; Tzianabos A; Anderson PW
    Infect Immun; 2006 Apr; 74(4):2187-95. PubMed ID: 16552049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to conserved pneumococcal antigens correlate with, but are not required for, protection against pneumococcal colonization induced by prior exposure in a mouse model.
    Trzcinski K; Thompson C; Malley R; Lipsitch M
    Infect Immun; 2005 Oct; 73(10):7043-6. PubMed ID: 16177389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant PhpA protein, a unique histidine motif-containing protein from Streptococcus pneumoniae, protects mice against intranasal pneumococcal challenge.
    Zhang Y; Masi AW; Barniak V; Mountzouros K; Hostetter MK; Green BA
    Infect Immun; 2001 Jun; 69(6):3827-36. PubMed ID: 11349048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal immunization with the cholera toxin B subunit-pneumococcal surface antigen A fusion protein induces protection against colonization with Streptococcus pneumoniae and has negligible impact on the nasopharyngeal and oral microbiota of mice.
    Pimenta FC; Miyaji EN; Arêas AP; Oliveira ML; de Andrade AL; Ho PL; Hollingshead SK; Leite LC
    Infect Immun; 2006 Aug; 74(8):4939-44. PubMed ID: 16861686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
    Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
    Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal vaccination with γ-irradiated Streptococcus pneumoniae whole-cell vaccine provides serotype-independent protection mediated by B-cells and innate IL-17 responses.
    Babb R; Chen A; Hirst TR; Kara EE; McColl SR; Ogunniyi AD; Paton JC; Alsharifi M
    Clin Sci (Lond); 2016 May; 130(9):697-710. PubMed ID: 26831937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotype-independent protection against pneumococcal infections elicited by intranasal immunization with ethanol-killed pneumococcal strain, SPY1.
    Xu X; Meng J; Wang Y; Zheng J; Wu K; Zhang X; Yin Y; Zhang Q
    J Microbiol; 2014 Apr; 52(4):315-23. PubMed ID: 24682994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against systemic fatal pneumococcal infection by maternal intranasal immunization with pneumococcal surface protein A (PspA).
    Katsurahara T; Hotomi M; Yamauchi K; Billal DS; Yamanaka N
    J Infect Chemother; 2008 Dec; 14(6):393-8. PubMed ID: 19089550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against Pneumococcal colonization and fatal pneumonia by a trivalent conjugate of a fusion protein with the cell wall polysaccharide.
    Lu YJ; Forte S; Thompson CM; Anderson PW; Malley R
    Infect Immun; 2009 May; 77(5):2076-83. PubMed ID: 19255193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the antibody response elicited by immunization with pneumococcal surface protein A (PspA) as recombinant protein or DNA vaccine and analysis of protection against an intranasal lethal challenge with Streptococcus pneumoniae.
    Vadesilho CF; Ferreira DM; Moreno AT; Chavez-Olortegui C; Machado de Avila RA; Oliveira ML; Ho PL; Miyaji EN
    Microb Pathog; 2012; 53(5-6):243-9. PubMed ID: 22981893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against nasal colonization with Streptococcus pneumoniae by parenteral immunization with a DNA vaccine encoding PspA (Pneumococcal surface protein A).
    Ferreira DM; Oliveira ML; Moreno AT; Ho PL; Briles DE; Miyaji EN
    Microb Pathog; 2010 Jun; 48(6):205-13. PubMed ID: 20206678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal immunization with PsaA protein, using chitosan as a delivery system, increases protection against acute otitis media and invasive infection by Streptococcus pneumoniae.
    Xu JH; Dai WJ; Chen B; Fan XY
    Scand J Immunol; 2015 Mar; 81(3):177-85. PubMed ID: 25565478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pertussis toxin improves immune responses to a combined pneumococcal antigen and leads to enhanced protection against Streptococcus pneumoniae.
    Salcedo-Rivillas C; Debrie AS; Miyaji EN; Ferreira JM; Raw I; Locht C; Ho PL; Mielcarek N; Oliveira ML
    Clin Vaccine Immunol; 2014 Jul; 21(7):972-81. PubMed ID: 24807055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of SP1683 as a pneumococcal protein that is protective against nasopharyngeal colonization.
    Moens L; Hermand P; Wellens T; Wuyts G; Derua R; Waelkens E; Ysebaert C; Godfroid F; Bossuyt X
    Hum Vaccin Immunother; 2018 May; 14(5):1234-1242. PubMed ID: 29400602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
    Lu J; Sun T; Wang D; Dong Y; Xu M; Hou H; Kong FT; Liang C; Gu T; Chen P; Sun S; Lv X; Jiang C; Kong W; Wu Y
    Immunol Invest; 2015; 44(5):482-96. PubMed ID: 26107747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-17A mediates acquired immunity to pneumococcal colonization.
    Lu YJ; Gross J; Bogaert D; Finn A; Bagrade L; Zhang Q; Kolls JK; Srivastava A; Lundgren A; Forte S; Thompson CM; Harney KF; Anderson PW; Lipsitch M; Malley R
    PLoS Pathog; 2008 Sep; 4(9):e1000159. PubMed ID: 18802458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.